Insmed's market cap is currently $14.19B. The company's EPS TTM is $-5.555; its P/E ratio is ―; Insmed is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-1.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 305.21M	$ 245.36M	$ 188.46M	$ 164.41M	$ 136.47M
Gross Profit	$ 239.63M	$ 190.23M	$ 144.31M	$ 124.54M	$ 112.25M
Operating Income	$ -709.63M	$ -478.12M	$ -367.76M	$ -265.23M	$ -235.25M
EBITDA	$ -660.18M	$ -429.44M	$ -375.09M	$ -250.37M	$ -215.67M
Net Income	$ -749.57M	$ -481.53M	$ -434.65M	$ -294.09M	$ -254.34M
Balance Sheet
Cash & Short-Term Investments	$ 780.45M	$ 1.15B	$ 716.78M	$ 532.76M	$ 487.43M
Total Assets	$ 1.33B	$ 1.66B	$ 1.24B	$ 796.15M	$ 742.30M
Total Debt	$ 1.20B	$ 1.18B	$ 612.27M	$ 404.84M	$ 397.04M
Net Debt	$ 721.62M	$ 103.83M	$ -104.51M	$ -127.91M	$ -90.39M
Total Liabilities	$ 1.66B	$ 1.57B	$ 833.04M	$ 520.27M	$ 480.63M
Stockholders' Equity	$ -331.92M	$ 87.95M	$ 410.47M	$ 275.88M	$ 261.67M
Cash Flow
Free Cash Flow	$ -549.53M	$ -410.32M	$ -370.59M	$ -226.17M	$ -292.92M
Operating Cash Flow	$ -536.25M	$ -400.44M	$ -363.30M	$ -219.35M	$ -250.65M
Investing Cash Flow	$ -223.60M	$ -34.58M	$ -64.28M	$ -6.82M	$ -42.27M
Financing Cash Flow	$ 168.44M	$ 793.27M	$ 612.55M	$ 271.00M	$ 285.28M

Currency in USD

Insmed Earnings and Revenue History

Income Statement >

Insmed Debt to Assets

Balance Sheet >

Insmed Cash Flow

Cash Flow >

Insmed Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing